| Application no. and date | 20815902.0 (espacenet) (Federated) (European Patent Register), 20201118 | | Patent/reg. no. and date | DK/EP 4061344, 20240529 | | Publication date | 20220928 | | Priority no. and date | GB 201916974, 20191121 | | EP pub. no. and date |
EP 4061344 20220928 | | Effective date | | | Applicant/owner | GW Research Limited, Sovereign House Vision Park
Chivers Way
Histon
Cambridge, Cambridgeshire CB24 9BZ, GB | | Applicant ref. no. | V2406-004-DK | | Inventor | GUY, Geoffrey,
Kent ME9 8AG, GB,
WOOLLEY-ROBERTS, Marie,
Kent ME9 8AG, GB,
WHALLEY, Benjamin,
Kent ME9 8AG, GB,
KNAPPERTZ, Volker,
Kent ME9 8AG, GB | | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | | Opponent | | | IPC Class | A61K 31/05 (2006.01) , A61P 25/08 (2006.01) | | Title | 6-HYDROXYCANNABIDIOL TIL ANVENDELSE SOM LÆGEMIDDEL | | Int. application no. | GB2020052942 | | Int. publication no. | WO2021099781 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
